To assess the potential for ingestion of yogurt to modulate immunity, its e
ffects on basal gene expression of cytokines in systemic and mucosal sites
were determined in mice. Yogurts were manufactured from pasteurized nonfat
dry milk using five commercial starter cultures with or without Bifidobacte
rium sp. and Lactobacillus acidophilus. Treatment mice were fed the AlN-93G
diet mixed 1:1 with unheated yogurt or heat-treated yogurt (wt/wt) for 2 a
nd 4 weeks, and control mice were fed the AIN-93G diet mixed 1:1 (wt/wt) wi
th nonfat dry milli. The viability of the various bacterial groups in unhea
ted yogurts was maintained above 10(6) CFU/g throughout the feeding period.
The yogurt-feeding regimens did not significantly affect weight gain. Rela
tive mRNA levels in spleen, mesenteric lymph nodes, or Peyer's patches for
the cytokines interferon-gamma, tumor necrosis factor-alpha, interleukin-2,
-4, and -6, and the "housekeeping gene" beta(2)-microglobulin were determi
ned by reverse transcriptase-polymerase chain reaction in conjunction with
hybridization analysis. Prolonged feeding of some yogurts decreased express
ion of several cytokine mRNAs, the depression of tumor necrosis factor-alph
a mRNA in the spleen being the most prominent effect. Heat-treated yogurts
were more effective in altering cytokine mRNA expression than were unheated
yogurts containing viable organisms. Generally, yogurts either had no effe
ct or decreased specific cytokine mRNA in the test organs, regardless of wh
ether they contained Bifidobacterium sp. and L. acidophilus. These results
suggest that, in contrast with previous studies in vitro, some yogurt formu
lations may reduce rather than stimulate basal cytokine expression and that
these effects are most prominent in the systemic compartment.